University of Groningenfounded in 1614  -  top 100 university
Close
Research Research database

Pharmacotherapy and Pharmaceutical Care

University of Groningen > Faculty of Science and Engineering > Faculty Board FSE > FSE Research > Groningen Research Institute of Pharmacy > Pharmacotherapy and Pharmaceutical Care

Advanced
Advanced

Reset

to
351 - 400 out of 1,207Page size: 50
  1. 2013
  2. Penning, R., McKinney, A., Bus, L. D., Olivier, B., Slot, K., & Verster, J. C. (2013). Measurement of alcohol hangover severity: Development of the Alcohol Hangover Severity Scale (AHSS). Psychopharmacology, 225(4), 803-810. https://doi.org/10.1007/s00213-012-2866-y
  3. Ahmed, A. I. A., Ali, A. N. A., Kramers, C., Harmark, L. V. D., Burger, D. M., & Verhoeven, W. M. A. (2013). Neuropsychiatric Adverse Events of Varenicline A Systematic Review of Published Reports. Journal of Clinical Psychopharmacology, 33(1), 55-62. https://doi.org/10.1097/JCP.0b013e31827c0117
  4. Wielema, M. L., DeGraaf, D., De Groot, J., Passier, J. L. M., & Van Roon, E. N. (2013). Hypersensitivity reaction to ranitidine: Two case reports and review of the use of H2-antagonists in prophylactic treatment against hypersensitivity reactions. Pharmaceutische Weekblad Wetenschappelijk Platform, 148(3), 10-13.
  5. Mol, P. G. M., Van Den Bemt, P. M. L. A., Dequito, A. B., Van Doormaal, J. E., Zaal, R. J., Haaijer-Ruskamp, F. M., & Kosterink, J. G. W. (2013). Preventable and non-preventable medication-related injuries in the hospital. Nederlands Tijdschrift voor Geneeskunde, 157(6).
  6. Cohen, D., & Loonen, A. J. M. (2013). Are immediate- and extended-release drugs interchangeable? Acta Psychiatrica Scandinavica, 127(1), 78-80. https://doi.org/10.1111/acps.12015
  7. Harmark, L., Lie-Kwie, M., Berm, L., de Gier, H., & van Grootheest, K. (2013). Patients' motives for participating in active post-marketing surveillance. Pharmacoepidemiology and Drug Safety, 22(1), 70-76. https://doi.org/10.1002/pds.3327
  8. Rolfes, L., van Hunsel, F., van Puijenbroek, E., & van Grootheest, A. (2013). Adverse Drug Reaction Reports of Patients and Healthcare Professionals: How Different Are They?. Abstract from International Conference on Pharmacoepidemiology & Therapeutic Risk Management, Canada.
  9. Wilffert, B. (2013). Afwegingen en besluitvorming door toelatingsautoriteiten. Pharmaceutische Weekblad Wetenschappelijk Platform, 7, e1335.
  10. Postma, M. J., Kappelhoff, B. S., van Hulst, M., & Brouwers, J. R. B. J. (2013). Author response: economic evaluation of dabigatran etexilate. Journal of Medical Economics, 16(3), 372-373.
  11. Vu Dinh Hoa (2013). Clinical pharmacology of tuberculosis drugs and tuberculosis control in developing world: the involvement of private pharmacy and the individualization of treatment using dried blood spot. University of Groningen.
  12. Maurer, J. M., Schellekens, R. C. A., Van Rieke, H. M., Stellaard, F., Wutzke, K. D., Buurman, D. J., Dijkstra, G., Woerdenbag, H. J., Frijlink, H. W., & Kosterink, J. G. W. (2013). ColoPulse tablets perform comparably in healthy volunteers and Crohn's patients and show no influence of food and time of food intake on bioavailability. Journal of controlled release : official journal of the Controlled Release Society, 172(3), 618-624. https://doi.org/10.1016/j.jconrel.2013.09.021
  13. Lako, I. M. (2013). Depressive symptoms in patients with schizophrenia: count symptoms that count. s.n.
  14. Broesamle, T. C. (2013). Designing health care services using systems thinking: a theory, a method and their application in the Dutch community pharmacy. s.n.
  15. Geurts, M. M. E., Ivens, M., van Gelder, E., & de Gier, J. J. (2013). Development of a web-based pharmaceutical care plan to facilitate collaboration between healthcare providers and patients. Journal of Innovation in Health Informatics, 21(1), 53-59. https://doi.org/10.14236/jhi.v21i1.40
  16. van Hasselt, F. M. (2013). Improving the physical health of people with severe mental illness: the need for tailor made care and uniform evaluation of interventions. s.n.
  17. Jessurun, N. T., & van Puijenbroek, E. P. (2013). Interacties tussen cumarinederivaten en antimycotica: ook mogelijk bij cutaan gebruik van antimycotica. Nederlands Tijdschrift voor Geneeskunde, 157, [A5317].
  18. Wilffert, B. (2013). LPA-polymorfisme karakteriseert hartpatiënten die kwetsbaar zijn ondanks statines. Pharmaceutische Weekblad Wetenschappelijk Platform, 7, e1335.
  19. Wilffert, B. (2013). Ongeschikte medicatie bij ouderen opsporen met Nederlandse versie STOPP en START. Pharmaceutische Weekblad Wetenschappelijk Platform, 7(2), e1304.
  20. Wilffert, B. (2013). Proteomics voor schatting nierschade bij diabetici. Pharmaceutische Weekblad Wetenschappelijk Platform, 7(1), e1305.
  21. 2012
  22. Ravera, S., Van Rein, N., De Gier, J. J., & De Jong-van Den Berg, L. T. W. (2012). Verkeersongevallen en psychofarmaca: Een Nederlandse case-controle-studie. Pharmaceutisch Weekblad, 147(50), 203-208.
  23. Ravera, S., Monteiro, S. P., de Gier, J. J., van der Linden, T., Gomez-Talegon, T., Javier Alvarez, F., & DRUID Project WP4 Partners (2012). A European approach to categorizing medicines for fitness to drive: outcomes of the DRUID project. British Journal of Clinical Pharmacology, 74(6), 920-931. https://doi.org/10.1111/j.1365-2125.2012.04279.x
  24. Nguyen, H. T., Wirtz, V. J., Haaijer-Ruskamp, F. M., & Taxis, K. (2012). Indicators of quality use of medicines in South-East Asian countries: a systematic review. Tropical Medicine & International Health, 17(12), 1552-1566. https://doi.org/10.1111/j.1365-3156.2012.03081.x
  25. Vu, D. H., van Rein, N., Cobelens, F. G. J., Nguyen, T. T. H., Le, V. H., & Brouwers, J. R. B. J. (2012). Suspected tuberculosis case detection and referral in private pharmacies in Viet Nam. International Journal of Tuberculosis and Lung Disease, 16(12), 1625-1629. https://doi.org/10.5588/ijtld.12.0295
  26. Risselad, A. J., Veho, J., Bruggeman, R., Wilffert, B., Cohen, D., Al Hadithy, A. F., Arends, J., & Mulder, H. (2012). De associatie tussen HTR2C-polymorfismen en de prevalentie van het metabool syndroom bij patiënten die antipsychotica gebruiken: Een replicatiestudie. Pharmaceutisch Weekblad, 147(46), 190-194.
  27. Quik, E. H., Feenstra, T. L., & Krabbe, P. F. M. (2012). Discrete event simulation: Modeling simultaneous complications and outcomes. Value in Health, 15(7), A472. https://doi.org/10.1016/j.jval.2012.08.1529
  28. Vu, D. H., Bolhuis, M. S., Koster, R. A., Greijdanus, B., de Lange, W. C. M., van Altena, R., Brouwers, J. R. B. J., Uges, D. R. A., & Alffenaar, J. W. C. (2012). Dried blood spot analysis for therapeutic drug monitoring of linezolid in patients with multidrug-resistant tuberculosis. Antimicrobial Agents and Chemotherapy, 56(11), 5758-5763. https://doi.org/10.1128/AAC.01054-12
  29. Chedoe, I., Molendijk, H., Hospes, W., Van den Heuvel, E. B., & Taxis, K. (2012). The effect of a multifaceted educational intervention on medication preparation and administration errors in neonatal intensive care. ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 97(6), F449-F455. https://doi.org/10.1136/fetalneonatal-2011-300989
  30. Van Hunsel, F., Van Welle, C. D., Passier, A., Van Puijenbroek, E., & Van Grootheest, K. (2012). Motieven voor het melden van bijwerkingen door patiënten in Nederland. Pharmaceutisch Weekblad, 147(42), 162-167.
  31. Hitzert, M. M., Bos, A. F., Bergman, K. A., Veldman, A., Schwarz, G., Santamaria-Araujo, J. A., Heiner-Fokkema, R., Sival, D. A., Lunsing, R. J., Arjune, S., Kosterink, J. G. W., & van Spronsen, F. (2012). Favorable outcome in a newborn with molybdenum cofactor type A deficiency treated with cPMP. Pediatrics, 130(4), e1005-e1010. https://doi.org/10.1542/peds.2011-3330
  32. Oosterhuis, I., Heijting, L., & van Puijenbroek, E. (2012). Spontaneous ejaculation with the use of noradrenergic reuptake inhibitors. European Journal of Clinical Pharmacology, 68(10), 1461-1462. https://doi.org/10.1007/s00228-012-1264-z
  33. Pijpker, M. J., & De Gier, J. J. (2012). Tarief medicatiebeoordeling doet geen recht aan tijdsbesteding: Prestatiebekostiging verdient extra impuls. Pharmaceutisch Weekblad, 147(36), 16-17.
  34. Lako, I. M., Bruggeman, R., Knegtering, H., Wiersma, D., Schoevers, R. A., Slooff, C. J., & Taxis, K. (2012). A systematic review of instruments to measure depressive symptoms in patients with schizophrenia. Journal of Affective Disorders, 140(1), 38-47. https://doi.org/10.1016/j.jad.2011.10.014
  35. Vehof, J., Burger, H., Wilffert, B., Al Hadithy, A., Alizadeh, B. Z., Snieder, H., & GROUP Investigators (2012). Clinical response to antipsychotic drug treatment: Association study of polymorphisms in six candidate genes. European Neuropsychopharmacology, 22(9), 625-631. https://doi.org/10.1016/j.euroneuro.2012.01.006
  36. Quee, P. J., Wiersma, D., Sytema, S., & Bruggeman, R. (2012). Cognitive adaptation training combined with assertive community treatment: A randomised longitudinal trial-A comment. Schizophrenia Research, 140(1-3), 264-265. https://doi.org/10.1016/j.schres.2012.06.015
  37. Loonen, A. J. M., Leonard, B. E., & van Praag, H. M. (2012). Little hope for further innovations in psychopharmacology? Human Psychopharmacology, 27(5), 437-439. https://doi.org/10.1002/hup.2252
  38. Maurer, M. J. M., Schellekens, R. C. A., Wutzke, K. D., Dijkstra, G., Woerdenbag, H. J., Frijlink, H. W., Kosterink, J. G. W., & Stellaard, F. (2012). A non-invasive, low-cost study design to determine the release profile of colon drug delivery systems: A feasibility study. Pharmaceutical Research, 29(8), 2070-2078. https://doi.org/10.1007/s11095-012-0735-3
  39. van Berlo-van de laar, I. R. F., Driessen, E., Merkx, M. M., & Jansman, F. G. A. (2012). Analysis of medication information exchange at discharge from a Dutch hospital. International Journal of Clinical Pharmacy, 34(4), 524-528. https://doi.org/10.1007/s11096-012-9639-x
  40. Zweers, P. G. M. A., Gilmour, N. J., Hepburn, P. A., Gerritsen, R. F., & van Puijenbroek, E. P. (2012). Causality methods in cosmetovigilance: Comparison of Colipa and PLM versus global introspection. Regulatory toxicology and pharmacology, 63(3), 409-417. https://doi.org/10.1016/j.yrtph.2012.05.005
  41. Harrison-Woolrych, M., Harmark, L., Tan, M., Maggo, S., & van Grootheest, K. (2012). Epistaxis and other haemorrhagic events associated with the smoking cessation medicine varenicline: A case series from two national pharmacovigilance centres. European Journal of Clinical Pharmacology, 68(7), 1065-1072. https://doi.org/10.1007/s00228-012-1220-y
  42. Geurts, M. M. E., Talsma, J., Brouwers, J. R. B. J., & de Gier, J. J. (2012). Medication review and reconciliation with cooperation between pharmacist and general practitioner and the benefit for the patient: a systematic review. British Journal of Clinical Pharmacology, 74(1), 16-33. https://doi.org/10.1111/j.1365-2125.2012.04178.x
  43. Quik, E. (2012). The somatotropic axis: Effects on brain and cognitive functions: De somatotrope as: Effecten op de hersenen en cognitieve functies . Uitgeverij BOXPress. http://www.boxpress-education.nl/proefschriften/the-somatotropic-axis-effects-on-brain-and-cognitive-functions.html
  44. Ravera, S., van Rein, N., de Gier, J. J., & de Jong-van den Berg, L. T. W. (2012). A comparison of pharmacoepidemiological study designs in medication use and traffic safety research. European Journal of Epidemiology, 27(6), 473-481. https://doi.org/10.1007/s10654-012-9689-3
  45. Nygard, P., Jansman, F. G. A., Kruik-Kolloffel, W. J., Barnaart, A. F. W., & Brouwers, J. R. B. J. (2012). Effects of short-term addition of NSAID to diuretics and/or RAAS-inhibitors on blood pressure and renal function. International Journal of Clinical Pharmacy, 34(3), 468-474. https://doi.org/10.1007/s11096-012-9631-5
  46. van Hasselt, F., & Loonen, A. (2012). Improving somatic health for outpatients with severe mental illness: the development of an intervention. International Journal of Neuropsychopharmacology, 15, 233-234. [P-21-008]. https://doi.org/10.1017/S1461145712000508
  47. Van Den Tweel, A. M. A., Van Hunsel, F. P. A. M., Derijks, H. J., Hermens, W. A. J. J., Van Puijenbroek, E. P., & Van Grootheest, A. C. (2012). Onderzoek naar het effect van een digitale meldmodule op het aantal gemelde bijwerkingen in een algemeen ziekenhuis. Pharmaceutisch Weekblad, 147(20), 79-84.
  48. Ravera, S., Ramaekers, J. G., de Jong-van den Berg, L. T. W., & de Gier, J. J. (2012). Are Selective Serotonin Reuptake Inhibitors Safe for Drivers? What is the Evidence? Clinical Therapeutics, 34(5), 1070-1083. https://doi.org/10.1016/j.clinthera.2012.04.002
  49. Ivanova, S. A., Al Hadithy, A. F. Y., Brazovskaya, N., Semke, A., Wilffert, B., Fedorenko, O., Brouwers, J. R. B. J., & Loonen, A. J. M. (2012). No involvement of the adenosine A2A receptor in tardive dyskinesia in Russian psychiatric inpatients from Siberia. Human Psychopharmacology, 27(3), 334-337. https://doi.org/10.1002/hup.2226
  50. Lako, I. M., Taxis, K., Bruggeman, R., Knegtering, H., Burger, H., Wiersma, D., & Slooff, C. J. (2012). The course of depressive symptoms and prescribing patterns of antidepressants in schizophrenia in a one-year follow-up study. European Psychiatry, 27(4), 240-244. https://doi.org/10.1016/j.eurpsy.2010.10.007
  51. Schaafstra, L., van Roon, E. N., Morssink, L. P., & de Vries, N. K. S. (2012). The effect of maternal ketanserin use on the circulation of the neonate: a prospective, observational study. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 162(1), 11-15. https://doi.org/10.1016/j.ejogrb.2012.01.013
  52. Dijkers, E. C. F., Munnink, T. H. O., De Vries, E. G. E., Brouwers, A. H., Jager, P. L., De Jong, J. R., Van Dongen, G. A. M. S., Schröder, C. P., Lub-De Hooge, M. N., & Kosterink, J. G. W. (2012). [89Zr]trastuzumab for PET imaging of HER2-positive lesions in patients with metastatic breast cancer. Pharmaceutisch Weekblad, 147(16), 62-67.
Previous 1...4 5 6 7 8 9 10 11 ...25 Next

ID: 32723

University of Groningen staff: edit these data

print
Follow the UGfacebook twitter linkedin rss instagram youtube